Clinical Trials for Takeda

Explore 208 clinical trials worldwide

Showing 1-50 of 208 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Takeda

Clinical Trials (208)

NCT05669729
A Survey to Assess Participants', Caregivers', and Nurses' Use and Understanding of Educational Material on Velaglucerase Alfa (VPRIV) Home Infusion
N/ANot yet recruiting
60 participants
Started: Sep 30, 2026 · Completed: Sep 30, 2027
1 condition1 sponsor0 locations
NCT06579755
A Study of Dengue Tetravalent Vaccine (TDV) in Adults (Age 45 to 60 and >60 to 79 Years)
PHASE3Not yet recruiting
800 participants
Started: Apr 1, 2026 · Completed: Apr 14, 2027
1 condition1 sponsor0 locations
NCT07218393
A Study About the Diagnosis and Management of Hereditary Angioedema (HAE) in Egypt
N/ANot yet recruiting
100 participants
Started: Dec 1, 2025 · Completed: Dec 1, 2026
1 condition1 sponsor7 locations
NCT07035886
A Study to Monitor the Fruzaqla Treatment of Adults With Metastatic Colorectal Cancer (mCRC) in South Korea
N/ANot yet recruiting
600 participants
Started: Nov 30, 2025 · Completed: Mar 1, 2031
1 condition1 sponsor0 locations
NCT06243731
A Study of Maribavir in Adults With Kidney Failure Who Have a Cytomegalovirus (CMV) Infection After Transplantation
N/ANot yet recruiting
10 participants
Started: Nov 30, 2025 · Completed: Jan 31, 2027
3 conditions1 sponsor0 locations
NCT06980480
A Study of Gammagard Liquid (Immune Globulin Infusion, 10%) to Prevent Infections in Adults With Multiple Myeloma
PHASE3Not yet recruiting
183 participants
Started: Nov 29, 2025 · Completed: Sep 11, 2028
2 conditions3 sponsors17 locations
NCT07205718
A Study of TAK-188 in Adults With Advanced or Spreading Solid Tumors
PHASE1/PHASE2Not yet recruiting
223 participants
Started: Nov 18, 2025 · Completed: Dec 21, 2029
1 condition1 sponsor15 locations
NCT07047521
A Study on a New Tetravalent Dengue Vaccine (TDV) Formulation in Healthy Adults
PHASE3Not yet recruiting
496 participants
Started: Nov 17, 2025 · Completed: Jul 30, 2027
1 condition1 sponsor5 locations
NCT07108283
A Study of Zasocitinib in Adults With Nonsegmental Vitiligo
PHASE2Not yet recruiting
200 participants
Started: Nov 14, 2025 · Completed: Nov 9, 2027
1 condition1 sponsor70 locations
NCT07187440
A Study of Agalsidase Alfa Enyzme Replacement Therapy in Chinese Children and Adults With Fabry Disease
N/ANot yet recruiting
200 participants
Started: Nov 7, 2025 · Completed: Nov 30, 2028
1 condition1 sponsor18 locations
NCT04563520
SAFE Study: Safety of aPCC Following Emicizumab Prophylaxis
PHASE3Recruiting
5 participants
Started: Oct 31, 2025 · Completed: Sep 30, 2026
1 condition2 sponsors2 locations
NCT06405087
A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)
PHASE3Not yet recruiting
70 participants
Started: Oct 27, 2025 · Completed: Jan 26, 2032
2 conditions1 sponsor0 locations
NCT07123350
Evaluating the Shift From Intravenous to Subcutaneous Vedolizumab for Inflammatory Bowel Disease
N/AActive, not recruiting
120 participants
Started: Oct 16, 2025 · Completed: Dec 31, 2025
3 conditions2 sponsors1 location
NCT07129343
A Study of Recombinant Von Willebrand Factor (rVWF) in Chinese Participants With Von Willebrand Disease (vWD)
PHASE3Not yet recruiting
20 participants
Started: Oct 12, 2025 · Completed: Nov 25, 2027
1 condition1 sponsor0 locations
NCT07204314
A Study of Vortioxetine in Japanese Pediatric Patients With Major Depressive Disorder
PHASE3Not yet recruiting
180 participants
Started: Oct 1, 2025 · Completed: Sep 30, 2029
1 condition1 sponsor0 locations
NCT07011576
A Study of Fruquintinib Plus FOLFIRI as Second-Line Treatment for Participants With Metastatic Colorectal Cancer (mCRC)
PHASE2Recruiting
60 participants
Started: Sep 29, 2025 · Completed: Jun 30, 2027
4 conditions2 sponsors10 locations
NCT07136077
A Phase 2 Trial of Fruquintinib and Tislelizumab in ctDNA-defined Minimal Residual Disease in Colorectal Cancer After Completion of Adjuvant Chemotherapy
PHASE2Active, not recruiting
20 participants
Started: Sep 18, 2025 · Completed: Apr 1, 2028
6 conditions3 sponsors1 location
NCT07042685
Trial of 5-Fluorouracil (5FU)-Based Therapy in Combination With Fruquintinib in Patients With Locally Advanced Unresectable or Metastatic Colorectal Cancer
PHASE2Not yet recruiting
50 participants
Started: Aug 31, 2025 · Completed: Dec 31, 2029
1 condition2 sponsors1 location
NCT06948318
A Continuation Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
PHASE3Recruiting
150 participants
Started: Aug 14, 2025 · Completed: Jul 29, 2029
1 condition1 sponsor1 location
NCT07111559
Lacunar Stroke hyperAcute Clinical Utilization of Novel Approach Regimens: Rt-PA vs. DAPT Randomised Clinical Trial
PHASE4Recruiting
500 participants
Started: Aug 1, 2025 · Completed: Mar 31, 2029
3 conditions3 sponsors13 locations
NCT06550882
A Study of OBIZUR in Adults With Acquired Hemophilia A (AHA) in South Korea
N/ARecruiting
9 participants
Started: Jul 22, 2025 · Completed: Sep 30, 2026
1 condition1 sponsor1 location
NCT06963827
A Study of Mezagitamab in Adults With Primary IgA Nephropathy Kidney Condition
PHASE3Recruiting
347 participants
Started: Jul 15, 2025 · Completed: Jan 14, 2030
1 condition1 sponsor40 locations
NCT06973291
A Study Comparing Zasocitinib (TAK-279) With Deucravacitinib in Adults With Plaque Psoriasis
PHASE3Recruiting
600 participants
Started: Jul 9, 2025 · Completed: Jul 3, 2026
1 condition1 sponsor113 locations
NCT06973304
A Study of Teduglutide in Chinese Adults With Short Bowel Syndrome
PHASE3Recruiting
13 participants
Started: Jun 26, 2025 · Completed: Jul 28, 2027
1 condition1 sponsor4 locations
NCT06665035
A Study of 2 Doses of Tetravalent Dengue Vaccine (TDV) in Infants and Toddlers
PHASE3Recruiting
212 participants
Started: Jun 16, 2025 · Completed: Mar 3, 2030
1 condition1 sponsor4 locations
NCT06764615
A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD)
PHASE2Recruiting
183 participants
Started: May 28, 2025 · Completed: Dec 30, 2029
2 conditions1 sponsor1 location
NCT06798012
A Study of TAK-411 in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
PHASE2Recruiting
36 participants
Started: May 14, 2025 · Completed: Jun 8, 2028
1 condition1 sponsor22 locations
NCT06952699
A Study of TAK-360 in Adults With Narcolepsy Without Cataplexy (NT2)
PHASE2Recruiting
40 participants
Started: May 6, 2025 · Completed: Apr 23, 2026
1 condition1 sponsor30 locations
NCT06747351
A Study to Compare TAK-881 and HYQVIA in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
PHASE3Recruiting
59 participants
Started: May 6, 2025 · Completed: Jun 25, 2028
1 condition2 sponsors52 locations
NCT06499285
The Efficacy and Safety of Elritercept in Adult Participants With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) With Anemia (RENEW)
PHASE3Recruiting
225 participants
Started: May 6, 2025 · Completed: May 31, 2032
1 condition2 sponsors28 locations
NCT06750731
Study of Efficacy and Adherence to Subcutaneous vs. Intravenous Vedolizumab in Patients With Inflammatory Bowel Disease Using a Novel Remote MONITORing Intervention
N/ARecruiting
200 participants
Started: May 5, 2025 · Completed: Sep 30, 2026
3 conditions2 sponsors6 locations
NCT06538064
A Study of HyQvia in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) in Routine Clinical Care
N/ARecruiting
30 participants
Started: Apr 29, 2025 · Completed: Aug 17, 2027
1 condition1 sponsor15 locations
NCT06935266
A Study of TAK-881 With and Without Ramp-Up Dosing in Healthy Adults
PHASE1Recruiting
64 participants
Started: Apr 22, 2025 · Completed: Oct 21, 2025
1 condition1 sponsor1 location
NCT06581328
A Study of Vedolizumab in Adults With Ulcerative Colitis or Crohn's Disease in the Community Setting
PHASE4Recruiting
400 participants
Started: Mar 27, 2025 · Completed: Jun 1, 2028
2 conditions1 sponsor41 locations
NCT06671496
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic Medicines
PHASE3Recruiting
600 participants
Started: Mar 10, 2025 · Completed: Jan 26, 2028
1 condition1 sponsor123 locations
NCT06843226
A Study in Children and Adolescents on the Effectiveness of Takeda's Licensed Dengue Vaccine TDV Against Hospitalization Due to Dengue Disease
N/ARecruiting
70,000 participants
Started: Mar 5, 2025 · Completed: Dec 31, 2029
1 condition1 sponsor3 locations
NCT06671483
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines
PHASE3Recruiting
1,088 participants
Started: Mar 3, 2025 · Completed: Jan 28, 2028
1 condition1 sponsor198 locations
NCT06588868
Systemic Therapies in the Treatment of Cutaneous T-cell Lymphoma
N/ARecruiting
400 participants
Started: Feb 27, 2025 · Completed: Jul 31, 2026
3 conditions2 sponsors18 locations
NCT06722235
A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
PHASE3Recruiting
171 participants
Started: Feb 27, 2025 · Completed: Dec 28, 2027
1 condition1 sponsor71 locations
NCT06841705
Early Vedolizumab As First-Line for Immune-Related Colitis Therapy Trial
PHASE2Not yet recruiting
80 participants
Started: Feb 25, 2025 · Completed: Dec 31, 2026
1 condition3 sponsors1 location
NCT06677892
A Study of Maribavir in Adults With Post-transplant Cytomegalovirus (CMV) Infection in Belgium
N/ARecruiting
75 participants
Started: Feb 24, 2025 · Completed: Sep 1, 2026
1 condition1 sponsor9 locations
NCT06787105
Fruquintinib in Patients With Metastatic Colorectal Cancer
N/ARecruiting
150 participants
Started: Feb 17, 2025 · Completed: Dec 31, 2027
1 condition2 sponsors1 location
NCT06565078
A Database Survey to Evaluate the Safety of Immune Globulin Subcutaneous (Human), 20% Solution in Participants with Primary Immunodeficiency
N/ARecruiting
100 participants
Started: Feb 17, 2025 · Completed: Jul 31, 2030
1 condition1 sponsor1 location
NCT06812078
A Study of TAK-360 in Adults With Idiopathic Hypersomnia
PHASE2Recruiting
40 participants
Started: Feb 7, 2025 · Completed: Feb 19, 2026
1 condition1 sponsor29 locations
NCT06741683
A Study of Dengue Tetravalent Vaccine (TDV) in Healthy Participants in Japan
PHASE2/PHASE3Active, not recruiting
187 participants
Started: Jan 31, 2025 · Completed: Dec 31, 2025
1 condition1 sponsor5 locations
NCT06100289
A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease
PHASE3Recruiting
70 participants
Started: Jan 22, 2025 · Completed: Jun 30, 2027
2 conditions1 sponsor57 locations
NCT06562543
A Trial to Evaluate the Safety and Activity of Fruquintinib in Minority Populations With Advanced, Previously Treated Colorectal Cancer
PHASE4Recruiting
78 participants
Started: Jan 14, 2025 · Completed: Oct 4, 2027
1 condition1 sponsor45 locations
NCT06227910
A Study of Vedolizumab With and Without Upadacitinib in Adults With Crohn's Disease
PHASE3Recruiting
396 participants
Started: Jan 2, 2025 · Completed: Aug 1, 2028
1 condition1 sponsor138 locations
NCT06439342
A Study of Maribavir in Chinese Adults With Cytomegalovirus (CMV) Infections
PHASE3Recruiting
20 participants
Started: Dec 16, 2024 · Completed: Dec 31, 2026
1 condition1 sponsor12 locations
NCT06317220
Vedolizumab for the Treatment of Collagenous Gastritis
PHASE2Recruiting
10 participants
Started: Dec 3, 2024 · Completed: Oct 31, 2026
1 condition3 sponsors1 location